Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Oct;71(10):7663–7669. doi: 10.1128/jvi.71.10.7663-7669.1997

Targeted adenovirus-mediated gene delivery to T cells via CD3.

T J Wickham 1, G M Lee 1, J A Titus 1, G Sconocchia 1, T Bakács 1, I Kovesdi 1, D M Segal 1
PMCID: PMC192116  PMID: 9311849

Abstract

T cells are primary targets in numerous gene therapy protocols. However, the use of subgroup C adenovirus serotype 2 or 5 (Ad2 or Ad5) as a vector to transduce T cells is limited by its poor transduction efficiency for these cells. In this report we show that poor T-cell transduction results from these cells lacking both the primary Ad2-Ad5 receptor, used in attachment, and the secondary Ad receptor, which mediates entry of most adenovirus serotypes. These deficiencies were overcome by using a bispecific antibody (bsAb) with specificities for human CD3 and for a FLAG epitope genetically introduced into Ad5 (Ad.FLAG) to redirect the virus to human T cells. The anti-FLAG x anti-CD3 bsAb increased Ad.FLAG binding 30-fold, induced the efficient uptake of Ad.FLAG into the cells, and led to a 100- to 500-fold increase in the transduction of resting T cells. Moreover, fluorescence-activated cell sorter analysis showed that 25 to 90% of the T cells were transduced by the bsAb-complexed Ad.FLAG at multiplicities of infection between 20 and 100 active particles per cell. These results demonstrate that bsAbs can target Ad to non-Ad receptors on cells that are normally resistant to Ad, resulting in their efficient and specific transduction.

Full Text

The Full Text of this article is available as a PDF (184.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bai M., Harfe B., Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol. 1993 Sep;67(9):5198–5205. doi: 10.1128/jvi.67.9.5198-5205.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997 Feb 28;275(5304):1320–1323. doi: 10.1126/science.275.5304.1320. [DOI] [PubMed] [Google Scholar]
  3. Buschle M., Cotten M., Kirlappos H., Mechtler K., Schaffner G., Zauner W., Birnstiel M. L., Wagner E. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum Gene Ther. 1995 Jun;6(6):753–761. doi: 10.1089/hum.1995.6.6-753. [DOI] [PubMed] [Google Scholar]
  4. Cosset F. L., Russell S. J. Targeting retrovirus entry. Gene Ther. 1996 Nov;3(11):946–956. [PubMed] [Google Scholar]
  5. Cournoyer D., Caskey C. T. Gene therapy of the immune system. Annu Rev Immunol. 1993;11:297–329. doi: 10.1146/annurev.iy.11.040193.001501. [DOI] [PubMed] [Google Scholar]
  6. Douglas J. T., Rogers B. E., Rosenfeld M. E., Michael S. I., Feng M., Curiel D. T. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol. 1996 Nov;14(11):1574–1578. doi: 10.1038/nbt1196-1574. [DOI] [PubMed] [Google Scholar]
  7. Fields P. E., Gajewski T. F., Fitch F. W. Blocked Ras activation in anergic CD4+ T cells. Science. 1996 Mar 1;271(5253):1276–1278. doi: 10.1126/science.271.5253.1276. [DOI] [PubMed] [Google Scholar]
  8. Fiering S. N., Roederer M., Nolan G. P., Micklem D. R., Parks D. R., Herzenberg L. A. Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry. 1991;12(4):291–301. doi: 10.1002/cyto.990120402. [DOI] [PubMed] [Google Scholar]
  9. Freimuth P. A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor. J Virol. 1996 Jun;70(6):4081–4085. doi: 10.1128/jvi.70.6.4081-4085.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Garrido M. A., Perez P., Titus J. A., Valdayo M. J., Winkler D. F., Barbieri S. A., Wunderlich J. R., Segal D. M. Targeted cytotoxic cells in human peripheral blood lymphocytes. J Immunol. 1990 Apr 15;144(8):2891–2898. [PubMed] [Google Scholar]
  11. Goldman M. J., Wilson J. M. Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J Virol. 1995 Oct;69(10):5951–5958. doi: 10.1128/jvi.69.10.5951-5958.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Greber U. F., Willetts M., Webster P., Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell. 1993 Nov 5;75(3):477–486. doi: 10.1016/0092-8674(93)90382-z. [DOI] [PubMed] [Google Scholar]
  13. Hong S. S., Karayan L., Tournier J., Curiel D. T., Boulanger P. A. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 1997 May 1;16(9):2294–2306. doi: 10.1093/emboj/16.9.2294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Horvath J., Weber J. M. Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection. J Virol. 1988 Jan;62(1):341–345. doi: 10.1128/jvi.62.1.341-345.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Huang S., Endo R. I., Nemerow G. R. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol. 1995 Apr;69(4):2257–2263. doi: 10.1128/jvi.69.4.2257-2263.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Langeveld C. H., Jongenelen C. A., Schepens E., Stoof J. C., Bast A., Drukarch B. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci Lett. 1995 Jun 2;192(1):13–16. doi: 10.1016/0304-3940(95)11596-o. [DOI] [PubMed] [Google Scholar]
  17. Li W., Whaley C. D., Mondino A., Mueller D. L. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science. 1996 Mar 1;271(5253):1272–1276. doi: 10.1126/science.271.5253.1272. [DOI] [PubMed] [Google Scholar]
  18. Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996 Apr 12;272(5259):263–267. doi: 10.1126/science.272.5259.263. [DOI] [PubMed] [Google Scholar]
  19. Philipson L., Lonberg-Holm K., Pettersson U. Virus-receptor interaction in an adenovirus system. J Virol. 1968 Oct;2(10):1064–1075. doi: 10.1128/jvi.2.10.1064-1075.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Phillips J. H., Warner N. L., Lanier L. L. Correlation of biophysical properties and cell surface antigenic profile of Percoll gradient-separated human natural killer cells. Nat Immun Cell Growth Regul. 1983;3(2):73–86. [PubMed] [Google Scholar]
  21. Reinherz E. L., Meuer S., Fitzgerald K. A., Hussey R. E., Levine H., Schlossman S. F. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell. 1982 Oct;30(3):735–743. doi: 10.1016/0092-8674(82)90278-1. [DOI] [PubMed] [Google Scholar]
  22. Roelvink P. W., Kovesdi I., Wickham T. J. Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment. J Virol. 1996 Nov;70(11):7614–7621. doi: 10.1128/jvi.70.11.7614-7621.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Seth P., Brinkmann U., Schwartz G. N., Katayose D., Gress R., Pastan Ira, Cowan K. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. Cancer Res. 1996 Mar 15;56(6):1346–1351. [PubMed] [Google Scholar]
  24. Silver L., Anderson C. W. Interaction of human adenovirus serotype 2 with human lymphoid cells. Virology. 1988 Aug;165(2):377–387. doi: 10.1016/0042-6822(88)90582-x. [DOI] [PubMed] [Google Scholar]
  25. Thimmappaya B., Weinberger C., Schneider R. J., Shenk T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell. 1982 Dec;31(3 Pt 2):543–551. doi: 10.1016/0092-8674(82)90310-5. [DOI] [PubMed] [Google Scholar]
  26. Tomko R. P., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3352–3356. doi: 10.1073/pnas.94.7.3352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wattel E., Vanrumbeke M., Abina M. A., Cambier N., Preudhomme C., Haddada H., Fenaux P. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia. 1996 Jan;10(1):171–174. [PubMed] [Google Scholar]
  28. Weinacker A., Chen A., Agrez M., Cone R. I., Nishimura S., Wayner E., Pytela R., Sheppard D. Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem. 1994 Mar 4;269(9):6940–6948. [PubMed] [Google Scholar]
  29. Wickham T. J., Carrion M. E., Kovesdi I. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 1995 Dec;2(10):750–756. [PubMed] [Google Scholar]
  30. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993 Apr 23;73(2):309–319. doi: 10.1016/0092-8674(93)90231-e. [DOI] [PubMed] [Google Scholar]
  31. Wickham T. J., Roelvink P. W., Brough D. E., Kovesdi I. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol. 1996 Nov;14(11):1570–1573. doi: 10.1038/nbt1196-1570. [DOI] [PubMed] [Google Scholar]
  32. Wickham T. J., Segal D. M., Roelvink P. W., Carrion M. E., Lizonova A., Lee G. M., Kovesdi I. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol. 1996 Oct;70(10):6831–6838. doi: 10.1128/jvi.70.10.6831-6838.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES